InvestorsHub Logo
Followers 6
Posts 601
Boards Moderated 0
Alias Born 09/05/2013

Re: Dennisb68 post# 870

Thursday, 03/29/2018 9:14:45 AM

Thursday, March 29, 2018 9:14:45 AM

Post# of 3504
You know, earnings from early biotechs are always bad, I think mbrx had more going on than anticipated. I hope with their 3 (?) Possible drug candidates it isnt a double edged sword, where they need to burn 3 times the cash in trials which causes that much more dilution. Obviously odds of success improve but at what cost.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent MBRX News